(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

RECEPTOR QUIMÉRICO DE ANTÍGENO (CAR), VETOR DE EXPRESSÃO, COMPOSIÇÃO DE CÉLULA T ISOLADA E DO REFERIDO VETOR, USO DOS MESMOS E MÉTODO DE PREPARAÇÃO DAS REFERIDAS CÉLULA T

ArquivadaInvention PatentPCT · US2019017532

Application data

Number

112020016030

Type

Invention Patent

Filing

02/11/2019

Publication

12/08/2020

PCT

US2019017532

Progress at the INPI

  1. Filing02/11/19
  2. Publication12/08/20
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 05/19/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

US

See this company's full portfolio

Inventors

C. R. (pessoa física)

US

J. B. (pessoa física)

US

Technical data

Priority claims

US

62/629,103 · 02/11/2018

Abstract

A presente invenção refere-se a Tregs que expressam receptores quiméricos de antígeno (CAR) têm como alvo específico um antígeno presente na articulação de pacientes com RA para induzir uma resposta a imunossupressores localizada e eficaz.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

05/19/2026

RPI 2889

Parecer de pré-exame

#6.23

12/23/2025

RPI 2868

Adição na publicação

#15.35

12/07/2021

RPI 2657

Notificação de entrada na fase nacional - PCT

#1.3

12/08/2020

RPI 2605

Alteração de dados cadastrais

#1.1

10/20/2020

RPI 2598

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.